| Dr Chuck I-chi Huang, MD | |
|
1619 Nw Hawthorne Ave Ste 201, Grants Pass, OR 97526-6009 | |
| (541) 474-1020 | |
| Not Available |
| Full Name | Dr Chuck I-chi Huang |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 1619 Nw Hawthorne Ave Ste 201, Grants Pass, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598963522 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | A86000 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chuck I-chi Huang, MD 211 Yacht Club Way Apt 239, Redondo Beach, CA 90277-2067 Ph: (310) 909-9441 | Dr Chuck I-chi Huang, MD 1619 Nw Hawthorne Ave Ste 201, Grants Pass, OR 97526-6009 Ph: (541) 474-1020 |
News Archive
Healthcare options for seniors, including changes to Medicare, will be among the topics discussed at special community forums open to all Medicare-eligible individuals in Maricopa County.
The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."
Disorders caused by a leaky vasculature are more common than most people think. Despite ICU treatment, one third of the 27 million patients globally that suffer from sepsis, and up to 20% of the more than 5 million US patients with congestive heart failure die every year from their condition.
Pfizer Inc. announced today the discontinuation of a Phase 3 randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ aggressive non-Hodgkin lymphoma who are not candidates for intensive high-dose chemotherapy.
Current initiatives within the biopharmaceutical industry to adopt PAT (Process Analytical Technology) approaches in manufacturing, include activities in early process development.
› Verified 1 days ago
Dr. Daniel S Selinger, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 495 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-476-6644 Fax: 541-472-5673 | |
Dr. Tarandeep Singh Arora, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 500 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-472-7000 | |
Mr. Roger Ward Steinbrenner, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 181 Nw Bunnell, Grants Pass, OR 97526 Phone: 541-479-7568 Fax: 541-479-7569 | |
Dr. Alexander Erino Bonato, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 500 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-472-7000 | |
Dr. John Spencer Countiss, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 495 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-476-6644 Fax: 541-472-5673 | |
Dr. Sheldon Junior Mckenzie, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 520 Sw Ramsey Avenue, Suite 205, Grants Pass, OR 97527 Phone: 541-507-2140 | |
Christian Stewart Holland, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1701 Nw Hawthorne Ave, Siskiyou Community Health Center, Grants Pass, OR 97526 Phone: 541-472-4777 |